Urology
-
To present the results of our experience with endoureterotomy as the initial management of ureterovesical junction obstruction (UVJO) with coexisting primary or secondary obstruction at the ureteropelvic junction (UPJO) level. ⋯ Performing initial endoureterotomy for the management of UVJO concomitant with UPJO provides promising results in spontaneous resolution of UPJO and complete resolution or decrease in hydronephrosis and can be proposed as an effective and safe temporizing alternative in selected patients.
-
Case Reports
Xanthogranulomatous orchiepididymitis: a very uncommon cause of scrotal mass in childhood.
Xanthogranulomatous orchitis (XGO) is an extremely rare inflammatory destructive lesion of testis. We report a case of a 14-year-old boy who presented with painful right testicular mass and discharging scrotal fistulas. Serologic tumor markers were normal. ⋯ The definitive cure was achieved by orchiectomy and excision of the fistulous extension to the scrotum. Histopathological investigation was consistent with xanthogranulomatous process. Although XGO is very rare, the basic interest in the present report is considering this entity in the broad differential diagnosis spectrum of scrotal masses in childhood.
-
To evaluate the anthropometric measurements of body mass index, outer-abdominal fat (OAF) and intra-abdominal fat (IAF) for their utility in predicting perioperative complications following minimally invasive partial nephrectomy. ⋯ IAF is independently associated with complications following minimally invasive partial nephrectomy. With further validation, this measurement may prove useful in the preoperative risk stratification of patients with small renal masses.
-
To investigate the influence of diabetes mellitus (DM) on late genitourinary (GU) and gastrointestinal (GI) toxicity in patients treated with external beam radiotherapy (RT) for prostate cancer. ⋯ A greater incidence of late GU toxicity was seen in patients with DM treated for prostate cancer. This relationship might be useful when considering the treatment of patients with DM, especially those receiving dose-escalated RT or with a history of transurethral resection of the prostate.